Promotion of proliferation and invasion |
Periostin |
Promotion of tumor cell proliferation and invasion, chemoresistance and metastasis. Contributes to fibrogenesis and desmoplasia. |
Interaction with integrins α5β1 orα6β4 and subsequent activation of AKT and FAK, thereby promoting migration. |
(202; 211; 212; 242; 245) |
Thrombospondin-1 |
Promotion of CCA invasion and metastasis. Correlates with hypovascularity of iCCA. |
Activation of plasminogen/plasmin system and via upregulation of metalloproteinases. |
(247; 248) |
HGF |
Proliferation and possibly invasion in vitro
|
Activation of HGF receptor c-Met promotes CCA proliferation; HGF pregulation of CXCR4 expression in CCA cells |
(211) |
Tenascin-c |
Tnc expression at the invasive front correlates with poor prognosis. |
Not well investigated. Interacts with periostin. Tnc promotes survival and stemness in other tumors. |
(215) |
CXCL12 |
iCCA progression and invasion. |
MEK1/2, AKT activation in vitro and via activationof the canonical Wnt signaling pathway in vivo. |
(255–257) |
MMP2, MMP9 |
Promotion of tumor progression and invasion. |
ECM proteins degradation |
(216; 218) |
Promotion of survival |
PDGF-BB |
Promotion of tumor cell survival. |
PDGF-BB protects from TRAIL-induced apoposis through hedgehog-mediated signals. |
(220) |
Modulation of immune response |
IL-1β |
Enhancement of tumor cell migration and invasion via CXCL5. |
IL-1β from HSC induces Cxcl5 in tumor cells, thereby enhancing tumor cells migration and invasion. |
(260) |